Certified alternative EO-based ingredients enable customers to reduce Scope 3 greenhouse gas emissions while maintaining high performance standards
Brussels, April 8, 2026 - Syensqo and Shell Chemicals Europe B.V. have joined forces to supply mass-balanced, low-carbon EO solutions for the agricultural and industrial markets, enabling reduced product carbon footprint (PCF) without compromising performance.
Syensqo intends to introduce EO-based solutions made with Shell Chemicals’ lower-carbon feedstocks, which deliver up to 51% lower carbon footprint versus conventional EO[1], enabled through the use of carbon capture utilisation (CCU) credits via a mass-balance approach.
Verified under the ISCC Carbon Footprint Certification (CFC), these drop-in solutions allow customers to reduce the carbon footprint of their formulations without requalification, while maintaining performance, quality, and supply reliability.
“Customers are under increasing pressure to reduce the carbon footprint of their products without compromising performance or supply reliability,” said Chloé Masselon, Sustainability Director at Syensqo. “Combining certified low-carbon feedstocks with drop-in compatibility, these solutions offer a practical and immediate way to decarbonise formulations at scale while meeting evolving regulatory and market expectations.”
This initiative supports Syensqo’s One Planet ambition to reduce Scope 3 GHG emissions in Focus 5 categories[2] by 25% by 2030 compared to 2021 levels. It also demonstrates that reducing value chain emissions requires collaboration across the ecosystem, from raw material suppliers to ingredients providers to finished goods manufacturers.
[1] The stated 51% reduction applies to the carbon footprint of Shell Chemicals’ feedstocks. The overall product carbon footprint reduction depends on the proportion of low-carbon EO in the final formulation.
[2] Focus 5 categories of Scope 3 emissions: (a) purchased goods and services (b) fuel-and energy-related activities (c) processing of sold products (d) use of sold products and (e) end-of-life treatment of sold products.